- TAKE A LOOK AT TEAM Atlassian Corporation >
IF WE DO A % MOVE/ 100% WOULD BE THE BARE MINIMUM COULD WE GET 100% OUT OF TEAM IN 3 YEARS? $150--- $300
FROM SOME OF THE STUFF I AM READING- YES.
$35---$73---$134----$258-----$440!!!!------$305-----$184------$118 <---LOW--141.80 <---- CURRENT***
LT CHART.
OK I found it... the stock for Stoney.
Earnings May 25th.
And we've played it before.
ME--> $2
SOUTH SAN FRANCISCO, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co.(ME) , a leading human genetics and biopharmaceutical company, today released a new report on lupus, a chronic autoimmune disease that can in some severe cases lead to permanent tissue damage, and may affect the skin, joints, heart, lungs, kidneys, circulating blood cells, or brain. The report, which is powered by data from consenting 23andMe research participants, is available for its 23andMe+ members.
As we recognize Lupus Awareness Month, 23andMe’s new report includes helpful insight into a customer’s likelihood of developing this hard to diagnose autoimmune disease. Because lupus is so difficult to diagnose, there are a wide range of estimates on how many people are living with the condition that range from about 160,000 to more than 1.5 million in the United States, according to the Lupus Foundation of America. In 2021, the CDC estimated that about 200,000 people in the U.S. are living with systemic lupus erythematosus (SLE), the most common form of lupus.
“Lupus is notoriously difficult to diagnose,” said Noura Abul-Husn, MD, PhD, Vice President of Genomic Health at 23andMe. “Although the cause of lupus is not yet fully understood, researchers believe that a mix of genetics and environmental factors trigger an overactive immune (or "autoimmune") response. Understanding one’s genetic likelihood of developing the disease could help them better understand their overall risk.”
23andMe’s new report uses machine learning techniques to estimate an individual’s likelihood of being diagnosed with lupus. The estimate is made using a statistical model that includes more than 1,900 genetic markers and information on an individual’s ethnicity and sex assigned at birth. You can learn more about the science and methodology behind our new report in this white paper.
Note that 23andMe’s report on lupus can provide users with helpful information on their estimated genetic likelihood of being diagnosed with the condition. Still, it is not a substitute for clinical diagnosis and treatment.